The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 1-Reference-Cited by-同舟云学术

The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 1

Published:1999-09 Issue:17 Volume:9 Page:2497-2502
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Cody Wayne L.,Cai Cuiman,Doherty Annette M.,Edmunds Jeremy J.,He John X.,Narasimhan Lakshmi S.,Plummer Janet S.,Rapundalo Stephen T.,Rubin J. Ronald,Van Huis Chad A.,St-Denis Yves,Winocour Peter D.,Siddiqui M. Arshad

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference11 articles.

1. Thrombin and factor Xa inhibitors

2. Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications

3. Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 Modifications

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Studies on asymmetric synthesis of bicyclomycin precursors. A chemoenzymatic route to chiral 2,5-diketopiperazines and 2-oxa-bicyclo[4.2.2]decane-8,10-diones;Tetrahedron: Asymmetry;2017-09

2. Design of Serine Protease Inhibitors;Structure-Based Design of Drugs and Other Bioactive Molecules;2015-05-29

3. Prolinamide derivatives as thrombin inhibitors for the treatment of thrombin-mediated diseases: a patent evaluation of US2013296245;Expert Opinion on Therapeutic Patents;2014-09-17

4. Synthesis, antiplatelet aggregation activity, and molecular modeling study of novel substituted-piperazine analogues;Medicinal Chemistry Research;2010-09-02

5. ChemInform Abstract: The Design of Potent and Selective Inhibitors of Thrombin Utilizing a Piperazinedione Template. Part 1.;ChemInform;2010-06-12